---
title: "Jefferies initiates coverage of Mentari Therapeutics at Buy, sets price target at $30"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305028486.md"
description: "Jefferies initiated coverage of Mentari Therapeutics at Buy and set a price target of $30.The price target implies an upside of 87.5% from the Nov 9 close of $16.Explore more price target data and ratings for Mentari Therapeutics on the , and track all previous and future analyst recommendations in the dedicated News Flow.DisclaimerSelect reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice."
datetime: "2026-11-10T14:25:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305028486.md)
  - [en](https://longbridge.com/en/news/305028486.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305028486.md)
generator: "portal-rs"
---

# Jefferies initiates coverage of Mentari Therapeutics at Buy, sets price target at $30

Jefferies initiated coverage of Mentari Therapeutics at Buy and set a price target of $30.

The price target implies an upside of 87.5% from the Nov 9 close of $16.

Explore more price target data and ratings for Mentari Therapeutics on the , and track all previous and future analyst recommendations in the dedicated News Flow.

**Disclaimer**

Select reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [MTRI.US](https://longbridge.com/en/quote/MTRI.US.md)
- [JEF.US](https://longbridge.com/en/quote/JEF.US.md)

## Related News & Research

- [Wedbush initiates coverage of Mentari Therapeutics at Outperform, sets price target at $33](https://longbridge.com/en/news/305469432.md)
- [Mentari Therapeutics' Total Liabilities Rise to $78.61 Million From $10.26 Million at Year-End](https://longbridge.com/en/news/305668280.md)
- [MTRI: PACAP/CGRP pipeline targets more effective, less frequent migraine prevention](https://longbridge.com/en/news/305818527.md)
- [ADAR1 Capital Management reports acquisition of $34,571.592 in Mentari Therapeutics common shares](https://longbridge.com/en/news/304932745.md)
- [Mentari Therapeutics Presents Migraine Drug Pipeline, Targets First Clinical Data in 2027](https://longbridge.com/en/news/304878301.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**